Search research articles
Contact Us
Filters
Showing results (511-520 of 542) with videos related to
Page
of 55
Sort By:
The Journal of Infectious Diseases
|
November 4, 2005
Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study
David W Haas, Laura M Smeaton, Robert W Shafer, et al.
HIV Clinical Trials
|
October 30, 2003
A multi-investigator/institutional DNA bank for AIDS-related human genetic studies: AACTG Protocol A5128
David W Haas, Grant R Wilkinson, Daniel R Kuritzkes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 29, 2020
Effects of Pregnancy and Isoniazid Preventive Therapy on Mycobacterium tuberculosis Interferon Gamma Response Assays in Women With HIV
Adriana Weinberg, Lisa Aaron, Grace Montepiedra, et al.
Pneumologie (Stuttgart, Germany)
|
October 11, 2017
[Consensus-Based Guidelines for Diagnosis, Prevention and Treatment of Tuberculosis in Children and Adolescents - A Guideline on Behalf of the German Society for Pediatric Infectious Diseases (DGPI)]
C Feiterna-Sperling, F Brinkmann, C Adamczick, et al.
Plos One
|
August 20, 2009
HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins
Zabrina L Brumme, Mina John, Jonathan M Carlson, et al.
Leukemia
|
July 2, 2020
PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis
E G Garcia, A Veloso, M L Oliveira, et al.
Scientific Reports
|
August 19, 2017
Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles
Rebecca Pavlos, Elizabeth J McKinnon, David A Ostrov, et al.
Pharmacogenetics and Genomics
|
June 12, 2023
Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis
Nana Agyemang, Kimberly K Scarsi, Paxton Baker, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
March 15, 2014
Tuberculosis control in big cities and urban risk groups in the European Union: a consensus statement
N A van Hest, R W Aldridge, G de Vries, et al.
Memorias Do Instituto Oswaldo Cruz
|
July 15, 2026
Determinants of HIV-1 virologic suppression in HIV-associated tuberculosis in Brazil
Felipe Ridolfi, Gustavo Amorim, David W Haas, et al.
Page
of 55
Search research articles
Search
Showing results (511-520 of 542) with videos related to
Sort By:
Page
of 55
The Journal of Infectious Diseases
|
November 4, 2005
Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study
David W Haas, Laura M Smeaton, Robert W Shafer, et al.
HIV Clinical Trials
|
October 30, 2003
A multi-investigator/institutional DNA bank for AIDS-related human genetic studies: AACTG Protocol A5128
David W Haas, Grant R Wilkinson, Daniel R Kuritzkes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 29, 2020
Effects of Pregnancy and Isoniazid Preventive Therapy on Mycobacterium tuberculosis Interferon Gamma Response Assays in Women With HIV
Adriana Weinberg, Lisa Aaron, Grace Montepiedra, et al.
Pneumologie (Stuttgart, Germany)
|
October 11, 2017
[Consensus-Based Guidelines for Diagnosis, Prevention and Treatment of Tuberculosis in Children and Adolescents - A Guideline on Behalf of the German Society for Pediatric Infectious Diseases (DGPI)]
C Feiterna-Sperling, F Brinkmann, C Adamczick, et al.
Plos One
|
August 20, 2009
HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins
Zabrina L Brumme, Mina John, Jonathan M Carlson, et al.
Leukemia
|
July 2, 2020
PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis
E G Garcia, A Veloso, M L Oliveira, et al.
Scientific Reports
|
August 19, 2017
Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles
Rebecca Pavlos, Elizabeth J McKinnon, David A Ostrov, et al.
Pharmacogenetics and Genomics
|
June 12, 2023
Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis
Nana Agyemang, Kimberly K Scarsi, Paxton Baker, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
March 15, 2014
Tuberculosis control in big cities and urban risk groups in the European Union: a consensus statement
N A van Hest, R W Aldridge, G de Vries, et al.
Memorias Do Instituto Oswaldo Cruz
|
July 15, 2026
Determinants of HIV-1 virologic suppression in HIV-associated tuberculosis in Brazil
Felipe Ridolfi, Gustavo Amorim, David W Haas, et al.
Page
of 55